Results of subtotal thyroidectomy for Graves' disease

Thyroid

Volumn 9, Issue 3, 1999, Pages 253-257

  Chou, Fong Fu ^a,b   Wang, Pei Wen ^a   Huang, Shun Chen ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b NONE   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHYROID AGENT; LIOTHYRONINE; LUGOL; MICROSOME ANTIBODY; PROPRANOLOL; PROPYLTHIOURACIL; THIAMAZOLE; THYROGLOBULIN ANTIBODY; THYROID ANTIBODY; THYROTROPIN; THYROXINE;

ADULT; ARTICLE; EUTHYROIDISM; FEMALE; FOLLOW UP; GRAVES DISEASE; HIGH RISK PATIENT; HUMAN; HUMAN TISSUE; HYPERTHYROIDISM; HYPOTHYROIDISM; LYMPHOCYTIC INFILTRATION; MAJOR CLINICAL STUDY; MALE; PREOPERATIVE CARE; PRIORITY JOURNAL; SUBTOTAL THYROIDECTOMY; TREATMENT OUTCOME;

EID: 0032908005     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.1999.9.253     Document Type: Article

References (29)

1. Patwardhan NA, Moront M, Rao S, Rossi S, Braverman LE 1993 Surgery still has a role in Graves hyperthyroidism. Surgery 114:1108-1113.
2. Ozoux JP, Calan LP, Portier G, Rivallain B, Favre JP, Robier A, Goga D, Brizon J 1988 Surgical treatment of Graves' disease. Am J Surg 156:177-180.
3. Menegaux F, Ruprecht T, Chiagot JP 1993 The surgical treatment of Graves' disease. Surg Gynecol Obstet 176:277-282.
4. Linos DA, Karakitsos D, Papademetriou J 1997 Should the primary Treatment of hyperthyroidism be surgical. Eur J Surg 163:651-657.
5. 131. A 16-year experience. JAMA 197:605-610.
6. Bardley EL, DiGirolamo M, Tarcan Y 1980 Modified subtotal thyroidectomy in the management of Graves' disease. Surgery 87:623-629.
7. Huang CS, Wang M, Shun CT, Liaw KY 1995 Factors affecting thyroid function after thyroidectomy for Graves' disease. J Formos Med Assoc 94:423-427.
8. Maier WP, Derrick BM, Marks AD, Channick BJ, Au FC, Caswell HT 1984 Long-term follow-up of patients with Graves' disease treated by subtotal thyroidectomy. Am J Surg 147:266-268.
9. McNeill AD, Thomson JA 1986 Long-term follow-up of surgically treated thyrotoxic patients. Br Med J 3:643-646.
10. Mazzaferi E 1990 Thyroid cancer and Graves' disease. Clin Endocrinol Metab 70:826-829.
11. Chou FF, Sheen-Chen SM, Chen YS, Chen MJ 1993 Hyperthyroidism and concurrent thyroid cancer. Int Surg 78: 343-346.
12. Fenz GF, Hashzume K, Roudebush GP, Degroot LJ 1979 Changes in thyroid stimulating immunoglobulins during antithyroid drug therapy. J Clin Endocrinol Metab 48:572-576.
13. Karlsson FA, Deblberg PA 1981 Thyroid stimulating antibody (TSAb) in patients with Graves' disease undergoing antithyroid drug treatment: Indications of activity of disease. Clin Endocrinol 14:579-585.
14. van Ouwerker BM, Krenning EP, Docter R, Bos G, van Oudenaren A, Brenner R, Hennemann G 1987 Cellular and humoval immunity in patients with hyperthyroid Grave's disease before, during and after antithyroid drug treatment. Clin Endocrinol 26:385-394.
15. Volpe RO, Karlsson A, Jansson R, Dahlberg PA 1987 Thyrostatic drugs act through modification of thyroid cell activity to induce remission in Graves' disease. Acta Endocrinol 281:305-311.
16. De Bruin TWA, Patwardhan NA, Brown RS, Braverman LE 1988 Graves' disease: Changes in TSH receptor and anti-microsomal antibodies after thyroidectomy. Clin Exp Immunol 72:481-485.
17. Kasuga Y, Sugenoya A, Kobayashi S, Shimizu T, Onuma H, Shingu K, Asanuma K, Hama Y, Iida F 1994 Significance of values of thyrotropin binding inhibitor immunoglobulins and appearance of intrathyroidal lymphocytes at subtotal thyroidectomy for disease. J Am Coll Surg 178:589-594.
18. Teng CS, Yeung TT, Khoo RKK, Alagaratnam TT 1980 A prospective study of the changes in thyrotropin binding inhibitory immunoglobulins in Graves' disease treated by subtotal thyroidectomy or radioactive iodine. J Clin Endocrinol Metab 50:1005-1010.
19. Ozaki O, Ito K, Mimura T, Sugino K, Ito K 1997 Factors affecting thyroid function after subtotal thyroidectomy for Graves' disease: Case control study by remnant-weight matched-pair analysis. Thyroid 7:555-559.
20. Harada T, Shimaoka K, Arita S, Nakanishi Y 1984 Follow-up evaluation of thyroid function after thyroidectomy for thyrotoxicosis. World J Surg 80:436-444.
21. Okamoto T, Fugimoto Y, Obara T, Ito Y, Aiba M 1992 Retrospective analysis of prognostic factors affecting the thyroid functional status after subtotal thyroidectomy for Graves' disease. World J Surg 16:690-696.
22. Sugino K, Mimura T, Ozaki O, Yoshio K, Iwasaki H, Wada N, Matsumoto A, Ito K 1995 Early recurrence of hyperthyroidism in patients with Graves' disease treated by subtotal thyroidectomy. World J Surg 19:648-652.
23. Sugino K, Mimura T, Toshima K, Iwabuchi H, Kitamura Y, Kawano M, Ozaki O, Ito K 1993 Follow-up evaluation of patients with Graves' disease treated by subtotal thyroidectomy and risk factor analysis for post-operative thyroid dysfunction. J Endocrinol Invest 16:195-199.
24. van Welsum M, Feltkamp TEW, de Vries MJ, Doctor R, Vanzij LJ, Hennemann G 1974 Hypothyroidism after thyroidectomy for Graves' disease: A search for an explanation. BMJ 4:755-756.
25. Busnardo B, Girelli ME, Rubello D, Eccher C, Betterle C 1988 Long term thyroid function after thyroidectomy for Graves' disease. J Endocrinol Invest 11:371-374.
26. Jortso E, Lennquist W, Lundstrom B, Norrby K, Smeds S 1987 The influence of remnant size, antithyroid antibodies, thyroid morphology, and lymphocyte infiltration on thyroid function after subtotal resection for hyperthyroidism. World J Surg 11:365-371.
27. Mitchie W, Beck JS, Pollet J 1978 Prevention and management of hypothyroidism after thyroidectomy for thyrotoxicosis. World J Surg 2:307-314.
28. Weetman AP, McGregor AM 1984 Autoimmune thyroid disease. Developments in our standing. Endocr Rev 5:309-355.
29. Farnell M, van Heerden AJ, McConahey WM, Carpenter HA, Wolff LH Jr 1981 Hypothyroidism after thyroidectomy for Grave's disease. Am J Surg 142:535-538.